APA (7th ed.) Citation

Mahmoud, T., Yagan, J., Hasan, A., Gheith, O. A., Mostafa, M., Rida, S., . . . Khalid, M. (2023). Sodium‐glucose co‐transporter 2 inhibitors & glucagon‐like peptide‐1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients. Clinical Transplantation, 37(12), 1. https://doi.org/10.1111/ctr.15144

Chicago Style (17th ed.) Citation

Mahmoud, Tarek, Jude Yagan, Amal Hasan, Osama A. Gheith, Mohamed Mostafa, Suzann Rida, Nabil El‐Serwi, Mohamad Shaker, and Mahmoud Khalid. "Sodium‐glucose Co‐transporter 2 Inhibitors & Glucagon‐like Peptide‐1 Receptor Agonists, Efficacy & Safety in Diabetic Kidney Transplant Recipients." Clinical Transplantation 37, no. 12 (2023): 1. https://doi.org/10.1111/ctr.15144.

MLA (9th ed.) Citation

Mahmoud, Tarek, et al. "Sodium‐glucose Co‐transporter 2 Inhibitors & Glucagon‐like Peptide‐1 Receptor Agonists, Efficacy & Safety in Diabetic Kidney Transplant Recipients." Clinical Transplantation, vol. 37, no. 12, 2023, p. 1, https://doi.org/10.1111/ctr.15144.